Pirfenidone Tablets

DRUG3 trials

Sponsors

Overseas Pharmaceuticals, Ltd., Guangdong Hengrui Pharmaceutical Co., Ltd

Conditions

Idiopathic Pulmonary FibrosisPulmonary Fibrosis

Phase 1

Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions

CompletedNCT06589921

Overseas Pharmaceuticals, Ltd.Idiopathic Pulmonary Fibrosis

Start: 2023-08-25End: 2023-09-14Updated: 2024-09-19

Comparative Pharmacokinetic(PK) Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions

CompletedNCT06588517

Overseas Pharmaceuticals, Ltd.Idiopathic Pulmonary Fibrosis

Start: 2024-04-08End: 2024-04-27Updated: 2024-09-19

Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects

RecruitingNCT07229716

Guangdong Hengrui Pharmaceutical Co., LtdPulmonary Fibrosis

Start: 2026-04-04End: 2026-05-01Target: 20Updated: 2026-04-27